Angiogenic CXC chemokine expression during differentiation of human mesenchymal stem cells towards the osteoblastic lineage

Journal of Cellular Biochemistry

Volumn 103, Issue 3, 2008, Pages 812-824

  Bischoff, D S ^a,b   Zhu, J H ^a   Makhijani, N S ^a   Kumar, A ^a   Yamaguchi, D T ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dexamethasone; ELR+ CXC chemokines; HMEC 1 angiogenesis; Human mesenchymal stem cells; Osteoblastic differentiation

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA CHEMOKINE; ASCORBIC ACID; CXCL1 CHEMOKINE; DEXAMETHASONE; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID RECEPTOR; GLYCEROL 2 PHOSPHATE; INTERLEUKIN 8; MESSENGER RNA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; SIGNAL TRANSDUCTION;

ANGIOGENESIS INDUCING AGENTS; BONE REGENERATION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINE CXCL1; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; MESENCHYMAL STEM CELLS; OSTEOBLASTS; SIGNAL TRANSDUCTION;

EID: 39049101075     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21450     Document Type: Article

References (47)

1. + chemokine-induced angiogenic activity. J Immunol 165:5269-5277.
2. Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: An update. Annu Rev Immunol 15:675-705.
3. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM. 2000. CXC chemokines in angiogenesis. J Leukoc Biol 68:1-8.
4. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, Santoni A, Capogrossi MC, Napolitano M. 2003. Analysis of the role of chemokines in angiogenesis. J Immunol Methods 273:83-101.
5. Bhattacharyya A, Pathak S, Datta S, Chattopadhyay S, Basu J, Kundu M. 2002. Mitogen-activated protein kinases and nuclear factor-κB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages. Biochem J 368:121-129.
6. Bosscher K, Vanden Berghe W, Haegeman G. 2003. Interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: Molecular mechanisms for gene repression. Endocr Rev 24:488-522.
7. Bowie AG, O'Neill LAJ. 2000. Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogen-activated protein kinase. J Immunol 165:7180-7188.
8. Carcamo JM, Pedraza A, Borquez-Ojeda O, Golde DW. 2002. Vitamin C suppresses TNFα-induced NFκB activation by inhibiting IκBα phosphorylation. Biochemistry 41:12995-13002.
9. Catelas I, Sese N, Wu BM, Dunn JC, Helgerson S, Tawil B. 2006. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng 12(8):2385-2396.
10. Charo IF, Ransohoff RM. 2006. The many roles of chemokines and chemokine receptors in inflammation. New Engl J Med 354:610-621.
11. Chaudary LR, Spelsberg TC, Riggs BL. 1992. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: Lack of regulation by 17 beta-estradiol. Endocrinology 130:2528-2534.
12. Cheng SL, Zhang SF, Avioli LV. 1996. Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cells. J Cell Biochem 61:182-193.
13. 3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone 31:269-275.
14. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. 2004. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117:2971-2981.
15. Delany AM, Dong Y, Canalis E. 1994. Mechanisms of glucocorticoid action in bone cells. J Cell Biochem 56:295-302.
16. Engelhardt E, Toksoy A, Goebeler M, Debus S, Brocker EB, Gillitzer R. 1998. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 153:1849-1860.
17. Fan H, Peck OM, Tempel GE, Halushka PV, Cook JA. 2004. Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation. Shock 22(1):57-62.
18. Foster LJ, Zeemann PA, Li C, Mann M, Jensen ON, Kassem M. 2005. Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 23:1367-1377.
19. Fournier PG, Chirgwin JM, Guise TA. 2006. New insights into the role of T cells in the vicious cycle of bone metastases. Curr Opin Rheumatol 18(4):396-404.
20. Gao Y, Tang S, Zhou S, Ware JA. 2001. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J Pharmacol Exp Ther 296(2):426-433.
21. Gazit D, Ebner R, Kahn AJ, Derynck R. 1993. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol 7:189-198.
22. Gillitzer R, Goebeler M. 2001. Chemokines in cutaneous wound healing. J Leukoc Biol 69:513-521.
23. Han S-S, Kim K, Hahm E-R, Lee SJ, Surh Y-J, Park HK, Kim WS, Jung CW, Lee MH, Park K, Yang J-H, Yoon S-S, Riordan NH, Riordan HD, Kimler BF, Park CH, Lee J-H, Park S. 2004. L-Ascorbic acid represses constitutive activation of NF-κB and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem 93:257-270.
24. Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, Otterson MF, Ota DM, Lugering N, Domschke W, Binion DG. 2003. Angiogenic effect of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are medicated by CXCR2. J Biol Chem 278:8508-8515.
25. Holtmann H, Winzen R, Holland P, Eickemeier S, Hoffmann E, Wallach D, Malinin NL, Cooper JA, Resch K, Kracht M. 1999. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol 19:6742-6753.
26. Hwang YS, Jeong M, Park JS, Kim MH, Lee DB, Shin BA, Mukaida N, Ellis LM, Kim HR, Ahn BW, Jung YD. 2004. Interleukin-1β stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. Oncogene 23:6603-6611.
27. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of purified culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
28. Jarrahy R, Huang W, Rudkin GH, Lee JM, Ishida K, Berry MD, Sukkarieh M, Wu BM, Yamaguchi DT, Miller TA. 2005. Osteogenic differentiation is inhibited and angiogenic expression is enhanced in MC3T3-E1 cells cultured on three-dimensional scaffolds. Am J Physiol Cell Physiol 289:C408-C414.
29. Kim DH, Yoo KH, Choi KS, Choi J, Choi S-Y, Yang S-E, Yang Y-S, Im HJ, Kim KH, Jung HL, Sung KW, Koo HH. 2005. Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell. Cytokine 31:119-126.
30. 2-terminal and nuclear factor-κB-inducing kinases. Am J Physiol Lung Mol Physiol 285:L464-L475.
31. Lisignoli G, Toneguzzi S, Pozzi C, Piacentini A, Riccio M, Ferruzzi A, Gualtieri G, Facchini A. 1999. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 26:791-799.
32. Lisignoli G, Toneguzzi S, Grassi F, Piacentini A, Tschon M, Cristino S, Gualtieri G, Facchini A. 2002. Different chemokines are expressed in human arthritic bone biopsies: IFN-γ and IL-6 differentially modulate IL-8, MCP-1 and RANTES production by arthritic osteoblasts. Cytokine 20:231-238.
33. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
34. McKay LI, Cidlowski JA. 1999. Molecular control of immune/inflammatory responses: Interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 20:435-459.
35. Mitsuyama H, Kambe F, Murakami R, Cao X, Ishiguro N, Seo H. 2004. Calcium signaling pathway involving calcineurin regulates interleukin-8 gene expression through activation of NF-κ in human osteoblast-like cells. J Bone Min Res 19:671-679.
36. Mukaida N, Mahe Y, Matsushima K. 1990. Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 265(34):21128-21133.
37. Murdoch C, Monk PN, Finn A. 1999. CXC chemokine receptor expression on human endothelial cells. Cytokine 11:704-712.
38. Rhen T, Cidlowski JA. 2005. Antiinflammatory action of glucocorticoids - New mechanisms for old drugs. N Engl J Med 353(16):1711-1723.
39. Rollins BR. 1997. Chemokines. Blood 90:909-928.
40. Rothe L, Collin-Osdoby P, Chen Y, Sunyer T, Chaudhary L, Tsay A, Goldring S, Avioli L, Osdoby P. 1998. Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology 139:4353-4363.
41. Saatian B, Zhao Y, He D, Georas SN, Watkins T, Spannhake EW, Natarajan V. 2006. Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells. Biochem J 393:657-668.
42. Schacke H, Docke WD, Asadullah K. 2002. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43.
43. Schepmoes G, Breen E, Owen TA, Aronow MA, Stein GS, Lian JB. 1991. Influence of dexamethasone on the vitamin-D-mediated regulation of osteoclacin gene expression. J Cell Biochem 47:184-196.
44. Street J, Bao M, deGuzman L, Bunting S, Peale FP, Jr., Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661.
45. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan S-Y, Roczniak S, Shanafelt AB. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348-27357.
46. Stromstedt PE, Poellinger L, Gustafson JA, Carlstedt-Duke J. 1991. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: A potential mechanism for negative regulation. Mol Cell Biol 11:3379-3383.
47. Szekanecz Z, Kim J, Koch AE. 2003. Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 15:15-21.